- Home
- ET vs TAK Comparison
ET vs TAK Comparison
Compare ET & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ET
- TAK
- Stock Information
- Founded
- ET 2002
- TAK 1781
- Country
- ET United States
- TAK Japan
- Employees
- ET N/A
- TAK N/A
- Industry
- ET Natural Gas Distribution
- TAK Biotechnology: Pharmaceutical Preparations
- Sector
- ET Utilities
- TAK Health Care
- Exchange
- ET Nasdaq
- TAK Nasdaq
- Market Cap
- ET 55.6B
- TAK 45.8B
- IPO Year
- ET 2006
- TAK N/A
- Fundamental
- Price
- ET $17.70
- TAK $15.04
- Analyst Decision
- ET Strong Buy
- TAK
- Analyst Count
- ET 12
- TAK 0
- Target Price
- ET $22.58
- TAK N/A
- AVG Volume (30 Days)
- ET 11.6M
- TAK 1.9M
- Earning Date
- ET 05-06-2025
- TAK 07-30-2025
- Dividend Yield
- ET 7.31%
- TAK 3.91%
- EPS Growth
- ET 20.71
- TAK N/A
- EPS
- ET 1.32
- TAK 0.45
- Revenue
- ET $82,062,000,000.00
- TAK $30,595,075,281.00
- Revenue This Year
- ET $10.54
- TAK $1.01
- Revenue Next Year
- ET $4.35
- TAK $1.04
- P/E Ratio
- ET $13.38
- TAK $65.06
- Revenue Growth
- ET 1.04
- TAK 7.45
- 52 Week Low
- ET $14.60
- TAK $12.58
- 52 Week High
- ET $21.45
- TAK $15.43
- Technical
- Relative Strength Index (RSI)
- ET 51.16
- TAK 58.89
- Support Level
- ET $17.34
- TAK $14.90
- Resistance Level
- ET $18.23
- TAK $15.09
- Average True Range (ATR)
- ET 0.37
- TAK 0.13
- MACD
- ET -0.02
- TAK 0.07
- Stochastic Oscillator
- ET 40.56
- TAK 94.21
About ET Energy Transfer LP Common Units
Energy Transfer owns one of the largest portfolios of crude oil, natural gas, and natural gas liquid assets in the US, primarily in Texas and the US midcontinent region. Its pipeline network includes more than 12,000 miles of intrastate pipelines and 20,000 miles of interstate pipelines. It also owns gathering, processing, and storage facilities in the largest US oil and gas producing regions. Other businesses include a network of natrual gas liquids and refined products facilities, 18,000 miles of crude oil pipelines, and the Lake Charles gas liquefaction facility. Energy Transfer combined its publicly traded limited and general partnerships in October 2018.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.